Tilray Brands, Inc. Increase (Decrease) in Accounts Receivable
Tilray Brands, Inc. (TLRY) reported Increase (Decrease) in Accounts Receivable of $66.42 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-28
- Tilray Brands, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-05-31 was $69.54M, a 283.73% increase year-over-year.
- Tilray Brands, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-02-28 was $9.30M.
- Tilray Brands, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-11-30 was $2.00M, a 70.25% decline year-over-year.
- Tilray Brands, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-08-31 was -$14.41M, a 715.46% decline year-over-year.
- Tilray Brands, Inc. increase (decrease) in accounts receivable for fiscal 2026 was $66.42M, a 273.14% increase from fiscal 2025.
- Tilray Brands, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $17.80M, a 170.74% increase from fiscal 2024.
- Tilray Brands, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $6.58M.
- Tilray Brands, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$4.17M, a 171.35% decline from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $69.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $78.84M derived: sum of 2 quarters · filed 2026-07-28 | $80.84M derived: sum of 3 quarters · filed 2026-07-28 | $66.42M 10-K · filed 2026-07-28 | |||
| 2026-02-28 | $9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $11.30M derived: sum of 2 quarters · filed 2026-04-01 | -$3.12M 10-Q · filed 2026-04-01 | $15.01M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-11-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$12.42M 10-Q · filed 2026-01-08 | $5.70M derived: sum of 3 quarters · filed 2026-07-28 | -$3.67M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-08-31 | -$14.41M 10-Q · filed 2025-10-09 | $3.71M derived: sum of 2 quarters · filed 2026-07-28 | -$5.66M derived: sum of 3 quarters · filed 2026-07-28 | $1.04M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-05-31 | $18.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $8.75M derived: sum of 2 quarters · filed 2026-07-28 | $15.46M derived: sum of 3 quarters · filed 2026-07-28 | $17.80M 10-K · filed 2026-07-28 | |||
| 2025-02-28 | -$9.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | -$2.66M derived: sum of 2 quarters · filed 2026-04-01 | -$321.00K 10-Q · filed 2026-04-01 | $11.83M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-11-30 | $6.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $9.05M 10-Q · filed 2026-01-08 | $21.20M derived: sum of 3 quarters · filed 2026-07-28 | $20.15M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-08-31 | $2.34M 10-Q · filed 2025-10-09 | $14.49M derived: sum of 2 quarters · filed 2026-07-28 | $13.44M derived: sum of 3 quarters · filed 2026-07-28 | $21.96M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-05-31 | $12.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $11.10M derived: sum of 2 quarters · filed 2026-07-28 | $19.62M derived: sum of 3 quarters · filed 2026-07-28 | $6.58M 10-K · filed 2026-07-28 | |||
| 2024-02-29 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | $7.47M derived: sum of 2 quarters · filed 2025-04-08 | -$5.58M 10-Q · filed 2025-04-08 | $8.31M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-11-30 | $8.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | -$4.52M 10-Q · filed 2025-01-10 | $9.36M derived: sum of 3 quarters · filed 2025-07-29 | -$2.00M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-08-31 | -$13.04M 10-Q · filed 2024-10-10 | $841.00K derived: sum of 2 quarters · filed 2025-07-29 | -$10.52M derived: sum of 3 quarters · filed 2025-07-29 | -$20.28M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-05-31 | $13.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $2.52M derived: sum of 2 quarters · filed 2025-07-29 | -$7.24M derived: sum of 3 quarters · filed 2025-07-29 | -$4.17M 10-K · filed 2025-07-29 | |||
| 2023-02-28 | -$11.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$21.12M derived: sum of 2 quarters · filed 2024-04-09 | -$18.05M 10-Q · filed 2024-04-09 | -$12.67M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-11-30 | -$9.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$6.69M 10-Q · filed 2024-01-09 | -$1.31M derived: sum of 3 quarters · filed 2024-10-10 | $1.89M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-08-31 | $3.07M 10-Q · filed 2024-10-10 | $8.45M derived: sum of 2 quarters · filed 2024-10-10 | $11.64M derived: sum of 3 quarters · filed 2024-10-10 | -$958.00K derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-05-31 | $5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $8.58M derived: sum of 2 quarters · filed 2024-07-30 | -$4.03M derived: sum of 3 quarters · filed 2024-07-30 | $5.84M 10-K · filed 2024-07-30 | -$5.84M 10-K · filed 2022-07-28 | ||
| 2022-02-28 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | -$9.41M derived: sum of 2 quarters · filed 2023-04-10 | $458.00K 10-Q · filed 2023-04-10 | $6.92M derived: sum of 4 quarters · filed 2023-07-26 | |||
| 2021-11-30 | -$12.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$2.73M 10-Q · filed 2023-01-09 | $3.73M derived: sum of 3 quarters · filed 2023-07-26 | ||||
| 2021-08-31 | $9.87M 10-Q · filed 2022-10-07 | $16.33M derived: sum of 2 quarters · filed 2023-07-26 | |||||
| 2021-05-31 | $6.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $23.51M 10-K · filed 2023-07-26 | -$23.51M 10-K · filed 2021-07-28 | ||||
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-10 | ||||||
| 2021-02-28 | -$11.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $17.05M 10-Q · filed 2022-04-06 | |||||
| 2020-12-31 | $4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$6.29M 10-K · filed 2021-02-19 | |||||
| 2020-11-30 | $6.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $28.57M 10-Q · filed 2022-01-10 | |||||
| 2020-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$11.07M 10-Q · filed 2020-11-09 | |||||
| 2020-08-31 | $21.66M 10-Q · filed 2021-10-07 | ||||||
| 2020-06-30 | -$11.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$9.14M 10-Q · filed 2020-08-10 | -$9.34M derived: sum of 3 quarters · filed 2021-05-10 | $3.46M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2020-05-31 | -$25.59M 10-K · filed 2022-07-28 | ||||||
| 2020-03-31 | $1.91M 10-Q · filed 2021-05-10 | $1.71M derived: sum of 2 quarters · filed 2021-05-10 | $14.51M derived: sum of 3 quarters · filed 2021-05-10 | $19.76M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | -$199.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $12.60M derived: sum of 2 quarters · filed 2021-02-19 | $17.85M derived: sum of 3 quarters · filed 2021-02-19 | $14.82M 10-K · filed 2021-02-19 | |||
| 2019-09-30 | $12.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $18.05M derived: sum of 2 quarters · filed 2020-11-09 | $15.02M 10-Q · filed 2020-11-09 | $13.10M 10-Q · filed 2019-11-13 | $26.72M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2019-06-30 | $5.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.22M 10-Q · filed 2020-08-10 | $1.99M 10-Q · filed 2019-08-13 | $13.92M derived: sum of 3 quarters · filed 2021-02-19 | $17.89M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2019-05-31 | $9.42M 10-K · filed 2021-07-28 | ||||||
| 2019-03-31 | -$3.03M 10-Q · filed 2020-05-11 | $8.67M derived: sum of 2 quarters · filed 2021-02-19 | $12.64M derived: sum of 3 quarters · filed 2021-02-19 | $13.36M derived: sum of 4 quarters · filed 2021-02-19 | |||
| 2018-12-31 | $11.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $15.67M derived: sum of 2 quarters · filed 2021-02-19 | $16.39M derived: sum of 3 quarters · filed 2021-02-19 | $16.51M 10-K · filed 2021-02-19 | |||
| 2018-09-30 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $4.69M derived: sum of 2 quarters · filed 2019-11-13 | $4.81M 10-Q · filed 2019-11-13 | $4.75M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $722.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $840.00K 10-Q · filed 2019-08-13 | $781.00K derived: sum of 3 quarters · filed 2020-03-02 | $917.00K derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $118.00K 10-Q · filed 2019-05-15 | $59.00K derived: sum of 2 quarters · filed 2020-03-02 | $195.00K derived: sum of 3 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $77.00K derived: sum of 2 quarters · filed 2020-03-02 | $507.00K 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $566.00K 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | $430.00K 10-Q · filed 2018-08-29 | ||||||
| 2016-12-31 | -$317.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |